Statin drugs and congenital anomalies

被引:20
作者
Gibb, H [1 ]
Scialli, AR [1 ]
机构
[1] Sci Int Inc, Alexandria, VA 22314 USA
关键词
D O I
10.1002/ajmg.a.30685
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:230 / 231
页数:2
相关论文
共 10 条
[1]   Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins [J].
Edison, RJ ;
Muenke, M .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 131A (03) :287-298
[2]   Epidemiology of holoprosencephaly in Hawaii, 1986-97 [J].
Forrester, MB ;
Merz, RD .
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2000, 14 (01) :61-63
[3]  
KHOURY MJ, 1983, PEDIATRICS, V71, P815
[4]   The VACTERL association: lessons from the Sonic hedgehog pathway [J].
Kim, JH ;
Kim, PCW ;
Hui, CC .
CLINICAL GENETICS, 2001, 59 (05) :306-315
[5]  
MCGUIRK CK, 2001, EDIATRICS, V108, P1
[6]  
Moog U, 2001, GENET COUNSEL, V12, P287
[7]  
Rittler M, 1996, AM J MED GENET, V63, P529, DOI 10.1002/(SICI)1096-8628(19960628)63:4<529::AID-AJMG4>3.0.CO
[8]  
2-J
[9]  
Roux C, 2000, AM J CLIN NUTR, V71, p1270S, DOI 10.1093/ajcn/71.5.1270s
[10]   NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES [J].
SMITH, DW ;
LEMLI, L ;
OPITZ, JM .
JOURNAL OF PEDIATRICS, 1964, 64 (02) :210-+